1/64
Looks like no tags are added yet.
Name | Mastery | Learn | Test | Matching | Spaced |
|---|
No study sessions yet.
tetrapeptide
the four chain unit thats comon to all Ig
N-terminus
the end of the Ab that varies and changes
gives the idiotype
C-terminus
the end of the Ab that is constant
gives the isotype
heavy chain
the two inner, longer parts of the antibody
light chain
the two short, outer parts of an antibody
can either be Kappa or Lambda
how many of each chain does an Ab have?
two of each
what are the chains of an Ab held together by?
disulfide bridges
Fab region
“antigen binding”
The regions vary
located in the N-terminus
Fc region
part of the Ab that binds to the cell surface
helps create effector funcitons
located in the C-terminus
hinge region
gives an Ab its flexibility
allows for antigen-independent binding and more coverage
located between CH1 and CH2
What does each domain of an antibody look like?
they have beta-pleated sheets
they fold into balloon shaped folds
immunoglobulin folds
where the folds of the heavy and light chains meet and contain the hypervariable regions where antigen is captured
where are the hypervariable regions located?
Fab region
How many hypervariable regions are there on each chain?
3 each
what are the functions of hypervariable regions?
determines antigen specificity
How do hypervariable regions perform their function?
at least four complimentary determining regions (CDRs) are involved
it also depends on the positioning of all 6 CDRs on a Fab arm
Isotype
the heavy chain is the constant region
the class of Ig changes
the amino acid sequence is identical for all Ab in that class type
Idiotype
classified by unique structures in the variable region of both chains
makes the Ab specific for an Ag
Allotype
genetic variants within the same species
having a lambda chain instead of a Kappa
structure of IgM
pentamer
four constant regions
the largest→callled the macroglobulin"
5 monomer units held together by J chain
function of IgM
triggers the classical complement pathway
opsonization
toxin neutralization
half life and potency of IgM
6 days
5-10%
which Ab is the only one that can pass through the placenta?
IgG
where are IgM found?
they are membrane bound to B cells as receptors
special characteristics of IgM
have no memory
the first Ig class produced
is the most efficient Ab due to its many binding sites
structure of IgG
monomer
3 constant regions
4 different subtypes that differ based on # of disulfide bonds
functions of IgG
provide immunity to newborn
bind complement pathway
opsonization
antibody dependent cellular cytotoxicity
agglutination
half life and potency of IgG
23 days
70-75%
which subclass of IgG is the most efficient?
IgG3 because it has the largest hinge region
special characteristics of IgG
high diffusion coefficient (can enter extravascular)
has memory response
structure of IgA
either a monomer of dimer
3 constant regions
2 subtypes (depends on location)
functions of IgA
partol mucosal surfaces
anti-inflammatory agent (downreg IgG)
where are the subtypes of IgA located?
IgA1 is mainly in serum (monomer)
IgA2 is found in secretions (dimer)
half life and potency of IgA
5 days
10-15%
whats special about IgA2?
it is produced by plasma cells
special characteristics of IgA
transported via transcytosis with Secretory component
found in neutrophils, monocytes, macrophages
secretory component (SC)
a protein that attaches to the Fc region around the hinge of alpha chians
strucutre of IgD
monomer
3 constant regions
unusually long hinge region
function of IgD
found on B cells (maturation/differentiation)
also found in serum
half-life and potency of IgD?
1-3 days
less than 0.001%
structure of IgE
monomer
4 constant regions
functions of IgE
meidates histamine and heparin release from mast cells
allergic reactions
anti-parasitic
half life and potency of IgE?
2-3 days
0.0005%
special characteristics of IgE
bind to eos, basos, tissue mast cells, and langerhans cells
primary response
First exposure to an antigen
lag phase: no Ab detection and none in serum for several days
log phase: Ab titere increases
plateau: Ab titer stabilizes and most B cells become plasma and some become memory
decline: Ab are catabolized
what is the primary class of Ab in primary response?
IgM
secondary reponse
same four phases as primary
the response changes
a subsequent exposure to the same antigen
shorter lag phase
longer plateau
more gradual of a decline
what Ab is the predominant one in the secondary response?
IgG
creates a higher total concentration
Erlich’s side-chain theory
1900s
certain cells have receptors for a specific antigen that appear before contact
Those receptors will break off and circulate as Ab
Jerne and Burnet addition
1950s
lymphs are genetically preprogrammed to respond to one antigen (only one isotype)
Deryer and Bennett addition
1965
separate genes code Constant and variable regions of Ig
which chain rearranges first?
the heavy chain
where are the heavy chain genes found?
chromosome 14
what are the variable regions on the heavy chain?
V D and J
How does the heavy chain rearrange?
one choice for each region (VDJ and C) are chosen and commits to one specificity for a B cell
where are the genes for the light chain found?
Kappa is found chromosome 2
lambda is found on chromosome 22
what are the variable regions for the light chain
V and J
which gene rearranges first on the light chain?
Kappa
how is lambda formed?
only if a nonfunctional product is produced on chromsome 2 (accounts for why Kappa is more prevalent)
what happens after light chain rearrangements?
The light chains combine with mu chains in maturing B cells to form IgM
how is class switching initiated?
by T helper cells and cytokines
how does class switching happen?
the C region is spliced off so another class combines with the same VDJ region
what is the product of class switching?
a different class of antibody witht eh same specificity for an antigen (IgM for a antigen becomes IgG for the same antigen)
monoclonal antibodies
antibodies that are derived from a single plasma cell to produce identical antibodies
what are the clincial applications of monoclonal anitbodies?
in vitro diagnostics
therapeutic treatments
autoimmune treatments